Skin cancer is the most common form of cancer and is increasing worldwide. Historically, the diagnosis of skin cancers has relied on a variety of conventional techniques, mainly biopsies, which are performed invasively. A wide variety of commercial diagnostic tools and ancillary techniques are available to detect this type of cancer.
Non-invasive skin cancer diagnosis includes technologies and methods such as dermoscopy, ultrasound, confocal microscopy, Raman spectroscopy, fluorescence spectroscopy, optical coherence tomography, thermography and electrical bioimpedance. However, these techniques have a number of negative aspects: they are invasive for the patient, they are not immediate (a sample must be taken to the laboratory), they are expensive, and they require highly specialised personnel and equipment.
In order to provide a solution to alleviate these drawbacks, the SkinSens project has been launched, the aim of which is to develop a thermo-optical sensor with an electrical reading to detect these skin alterations, designing a prototype that can be used for validation. Skinsens will have a significant social impact, especially in terms of public health, as it is a new solution that can be used in a simple and practical way as a “point of care” in medical centres and in surgical processes in hospitals, reducing the volume of complications and advances of the undiagnosed condition.
To carry out this research, a consortium was formed by Radiantis, ASE Optics Europe, Procarelight and the Institute of Photomedicine which, coordinated by secpho, has been a beneficiary of the Next Generation EU funds channelled by the Ministry of Industry, Trade and Tourism within the programme of support for Innovative Business Groups, whose objective is to digitalise the industry.
In this event, the results of the project will be presented to the secpho ecosystem and other entities that want to learn about the latest advances in the health sector. You can read more about the project here.
The results of the project will be presented to the secpho ecosystem and other entities that want to learn about the latest advances in the health sector.